North China Pharmaceutical Overview

  • Year Founded
  • 1953

Year Founded

  • Status
  • Public

  • Employees
  • 10,088

Employees

  • Stock Symbol
  • 600812

Stock Symbol

  • Share Price
  • $0.80
  • (As of Friday Closing)

North China Pharmaceutical General Information

Description

North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.

Contact Information

Website
www.ncpc.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 388 Heping East Road
  • Chang'an District
  • Shijiazhuang, Hebei 050015
  • China
+86 0311
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Manufacturing
Corporate Office
  • No. 388 Heping East Road
  • Chang'an District
  • Shijiazhuang, Hebei 050015
  • China
+86 0311

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

North China Pharmaceutical Stock Performance

As of 18-Apr-2025, North China Pharmaceutical’s stock price is $0.80. Its current market cap is $1.37B with 1.72B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.80 $0.80 $0.55 - $0.95 $1.37B 1.72B 33.5M $0.01

North China Pharmaceutical Financials Summary

As of 31-Dec-2024, North China Pharmaceutical has a trailing 12-month revenue of $1.38B.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 2,791,766 2,791,766 2,858,389 2,967,793
Revenue 1,375,462 1,375,462 1,430,441 1,559,119
EBITDA 223,912 223,912 213,546 114,810
Net Income 17,698 17,698 691 (102,343)
Total Assets 2,941,255 2,941,255 2,956,395 3,075,822
Total Debt 1,568,464 1,568,464 1,572,608 1,601,399
Public Fundamental Data provided by Morningstar, Inc. disclaimer

North China Pharmaceutical Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

North China Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9938272-B2 Hydrazine compound as blood coagulation factor xa inhibitor Active 22-May-2014
US-20170152259-A1 Hydrazine compound as blood coagulation factor xa inhibitor Active 22-May-2014
EP-3147283-B1 Hydrazine compound as blood coagulation factor xa inhibitor Active 22-May-2014
EP-3147283-A4 Hydrazine compound as blood coagulation factor xa inhibitor Active 22-May-2014
EP-3147283-A1 Hydrazine compound as blood coagulation factor xa inhibitor Active 22-May-2014 C07D471/04
To view North China Pharmaceutical’s complete patent history, request access »

North China Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

North China Pharmaceutical ESG

Risk Overview

Risk Rating

Updated October, 17, 2024

40.09 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,109

Rank

Percentile

Pharmaceuticals

Industry

of 861

Rank

Percentile

Pharmaceuticals

Subindustry

of 430

Rank

Percentile

To view North China Pharmaceutical’s complete esg history, request access »

North China Pharmaceutical FAQs

  • When was North China Pharmaceutical founded?

    North China Pharmaceutical was founded in 1953.

  • Where is North China Pharmaceutical headquartered?

    North China Pharmaceutical is headquartered in Shijiazhuang, China.

  • What is the size of North China Pharmaceutical?

    North China Pharmaceutical has 10,088 total employees.

  • What industry is North China Pharmaceutical in?

    North China Pharmaceutical’s primary industry is Biotechnology.

  • Is North China Pharmaceutical a private or public company?

    North China Pharmaceutical is a Public company.

  • What is North China Pharmaceutical’s stock symbol?

    The ticker symbol for North China Pharmaceutical is 600812.

  • What is the current stock price of North China Pharmaceutical?

    As of 18-Apr-2025 the stock price of North China Pharmaceutical is $0.80.

  • What is the current market cap of North China Pharmaceutical?

    The current market capitalization of North China Pharmaceutical is $1.37B.

  • What is North China Pharmaceutical’s current revenue?

    The trailing twelve month revenue for North China Pharmaceutical is $1.38B.

  • What is North China Pharmaceutical’s annual earnings per share (EPS)?

    North China Pharmaceutical’s EPS for 12 months was $0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »